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Of113 methylisocyanate(MIC)-exposedsubjectsstudiedinitiallyatBhopal,India,79,56, 68, and87werefollowedwith
clinical,lungfunction, radiographic, andimmunologic testsat3,6,12, 18, and24months.Thoughourcohortconsisted
ofsubjectsatallagesshowingavariedseverity ofinitialillness,fewerfemalesandyoungsubjectswereseen. Initiallyall
hadeyeproblems, butdominantsymptomswereexertionaldyspnea,cough,chestpain,sputun,andmuscleweakness.
Alargenumbershowedpenistentdepressionmixedwithanxiety withdistubancesofpersonalityparametes Theearly
radiographicchangeswerelungedema,overinflation,enlargedheart, pleuralscars, andconsolidation. Thepersistent
changesseenwereinterstitial deposits. Lungfimctionsshowedmainlyrestivechangeswithsmali airwayobstruction;
there was impairment ofoxygenexchange. Oxygenexchange improvedat3-6months, andspirometryimproved at 12
months, onlytodeclinelater. Theexpiratoryflowratespertainingtolargeandmediumairwayfunctionimproved, but
thoseforsmall airwaysremained low. Therewerechangesofalveolitis inbronchoalveolarlavagefluidonfiberopticbron-
choscopy, andin 11 cases positiveMIC-specific antibodies toIgM, IgG, andIgE weredemonstrated.
OnfoDlowup,only48%ofthesubjectswereclinicalystable, while50% showedfluctuations.Thirty-two percentofthe
subjects hadlungfunctionfluctuations. Detailedsequentialbehaviorover24yearswaspredictedfordyspnea, forced
vitalcapacity, maximumexpiratory flowrate(Q25-475), peakexpiratoryflowrate,Vo2,anddepressionscore. Amodel
forclinical behaviorexplainedatotalvarianceof52A%byusingthefactorsofcough, Pco2andX-rayzonesinaddition
toabovefive parameters. Thebehavioroftherailwaycolonygroup(1640patients) revealedasimilarpatternofillness.
When thisobserved pattern ofchanges wastransferred totheaffected Bhopalcity sections (with an equitable age-sex
distribution), ourmodelresultswereagainvalidated. ThusthepktureofMIC-induceddiseawseemssimilardespitethe
differencesforage-sexandinitialseverityofillnessinourcohortandinthepopulationofBhopalcity aspredictedbyour
model.
Introduction
Aleakofmethylisocyanate(MIC)from a40-tontankoccurred
inBhopal, India, onDecember2and3, 1984. Approximately 0.2
million residents wereexposed tohighconcentrations (over27
ppm) ofMIC. As a result, it is believed that 2500 died within
hours, about3100within amonth, and3289 over4years. Inad-
dition, in the first few days, many cattle, fowl, and other large
animals also perished.
IDepartmentofRespiratory Medicine andPsychiatry, Seth G. S. Medical Col-
lege and K. E. M. Hospital, Bombay 400012, India.
Address reprint requests toS. R. Kamat,DepartmentofRespiratory Medicine
and Psychiatry, SethG. S. MedicalCollegeandK. E. M. Hospital, Bombay400
012, India.
Fromdirectscrutinyofrecordsontheresidentsoftherailway
colony where the leak occurred, we determined that 30% of
originalvictimsmighthavepersistingchronicdisability. Inthis
colonyof10,000, 135diedwithin4weeks, 1640weretreatedby
doctors, and872 were admitted to hospitals.
Our study cohort consists of 113 subjects assessed within 3
monthsofexposure; initial findingshavebeenpublished (1,2).
Laterwereportedchangesinflow ratesandflow-volume(FV)
loop up to 18 months (3) and immunologic changes (4); these
resultssuggestedthatseveralvictimsdevelopedweak,MIC-spe-
cificantibodytitersinIgM,IgG,andIgE.Wedemonstratedpat-
ternsofinspiratorydomingintheFVloop(3). Similarpersistent
abnormalitiesweredemonstratedbyguineapigsbyAlarieetal.(5).
To study the sequential behavior of MIC-exposed and per-
sistently symptomatic subjects, wefollowedmostofourcohortKAMATETAL.
regularly for2years. Wealsodevelopedamodelonthebasisof
observed behavior for subjects in the railway colony and on
Bhopal citizensofaffectedareas. Thispaperdetailsourfindings.
Materials and Methods
Persistentlysymptomatic residentsofBhopal(exposedtothe
MICleak)whowereseenatourhospitalinBombaywithin7-90
daysofthe leakformthestudy cohort. Subjects were followed
after3,6, 12, 18, and24monthsusingaclinicalrespiratoryques-
tionnaire modeled on the BMRC (British Medical Research
Council)questionaire, whichwasusedearlierinourworkonoc-
cupational diseases (6).
Inadditiontophysicalexamination, the following tests were
conducted: chestradiography, spirometery (SteadWellsSpiro-
meter, W. E. Collins, Boston, MA); bronchodilator tests with
nebulized,3 stimulantaerosol; FV loop studies (Fleisch Pneu-
motachograph withCollin'sbodyboxandHewlett-Packard X-Y
recorder; minute ventilation, oxygenuptake atrestandduring
submaximalexercise(withclinicalendpointat4-5min); and(at
0and3months)arterialbloodgasesatrestandwithexercisewith
carboxyhemoglobin (COHb) and methemoglobin (MetHb)
(CO-oximeterandbloodgasanalyzer; Instrumentation Labora-
tories, Boston, MA). AtlatertimesCOHbandMetHbweredone
onlyinselectedabnormalsubjects. Clinicalgradingofrespira-
tory illness wasdoneonthebasisofthenumberandseverityof
symptoms; ascoreof0-2wasconsideredmild, 3-4moderate,
andabove 4severe.
FromtheFVloop, wemanuallycalculatedgasflow(V)at25,
50, and75%, peakexpiratory flow rate(PEFR), andPIFR(in-
spiratoryandexpiratoryflow) ratesatrespectivephasesandpeak
values). Thetransducers werecalibratedbefore andaftereach
reading, andanintegratorwasusedforderivingthevolume. Ox-
ygen uptakes were calculated from volumes measured in a
Douglas bag from the collected expired air. The chest radio-
graphswerereadtogetherbytwoobserversandclassifiedasnor-
mal, emphysema, cardiovascularchanges, orparenchymaland
interstitial deposits. The latter were categorized as punctate,
linear, micronodular, orreticular, alongwiththeirzonaldistri-
butions.
Serialobservations at3monthsandlaterincludedpsychiatric,
psychosocial, and personality dysfunction in the cooperative
group. In 12subjectsseriously illat 1-3months, weperformed
flexiblefiberopticbronchoscopywithbronchoalveolarlavage.
Ineightsubjects, lungbiopsy wasperformed (fivebyneedleand
threeopen). Fromthemoderately illgroup, 52ECGsand32RA
testsandantinuclearfactors weremeasuredattheinitialassess-
ment. In a few cases with large broncho-reversibilty, graded
histamineairwayhyperreactivity, lungvolumes, andcompliance
weremeasuredat3and6months. Immunologic studies(incol-
laboration with University ofPittsburgh, Pittsburgh, PA) with
radioallergic(RAST)andMIC-specificantibodiesweredonein
99subjects. Thesetestsweredonebypreparinganantigentagged
withMICtohumanserumalbumin(MIC-HAS). Itsefficacyand
specificity weretested inguineapigs, andantibody titers were
measuredbyenzyme-linked immunoassay (ELISA) inhibition
forIgG, IgM, andIgE. We also measuredtotal IgEand RAST
IgE with MIC-HSA (4).
StatisticalanalysesweredonebyStudent'st-tests,proportional
chi-square tests, and, forantibody titers, by linearregression.
ModelDevelopment
Aftertheinitialanalysesontheoriginalcohortat0(n = 113),
3 (n = 79), 6 (n = 56), 12 (n = 68), 18 (n = 68), and24 (n =
87) monthsby paired t-tests, we did intercorrelations by Pear-
son's correlation coefficients at all phases separately and to-
gether. Thishelpedustoidentify significantvariables tobeused
forevaluating sequentialchanges. Todefinechanges inamore
regularcohort(n=81; definedasthosewhoattendedat0and24
months andatleastoncemore), we substituted missing values
withtheaveragebehaviorandcomparedtheindividualbehavior.
Thesequentialbehaviorsintheoriginalcohort, asactualpatterns
of 24 selected tests, were categorized as stable, improving,
worsening, worseningafterearlyimprovement, andfluctuating.
Fromthesecategories, weselectednineparametersformultifac-
torialregression(cough, dyspnea, forcedvitalcapacity [FVC],
PEFR, maximum expiratory flow rate [MEFR 0.25-0.75],
Pco2, X-rayzones, Hamiltondepression score, andoxygenup-
take [Vo2]).
Toaccountfordifferencesofage-sexdistributionbetweenthe
originalandregularcohortandbetweentherailway colonypa-
tients and Bhopal city population, the following method was
used: forbothsexesandthreeagegroups(0-19,20-44, and45+
years) numberswerecalculatedseparatelyforactualproportions
ineachofthepopulations. From meanvalues ofparameters in
thecohort, anewmeanvaluewasderived. Onthebasisofinitial
knowndistributionineachgroup(asmodifiedbyage-sex), we
assumedforlaterperiodsaworsetransitionprobability for se-
quentialchanges. Thiswastansfrredtothenewpopulation; the
progress was found to be similar in all age-sex groups. The
originally selected(nine)variableswerethensubjectedtomulti-
factorial regression forall six phases, giving sixEigenvalues.
From these two-factor composite equations we used the SPSS
(Berkeley, CA)programtoderivetwo-factorscoresandseveri-
tyscoresforclose-factoranalyses. WeobtainedEigenvaluesand
derivedvariancetoexplainthecohortbehaviorbythismethod.
Results
Table 1 lists the sex-age distribution ofthe original cohort
studiedatourinstitute. Ifthedistanceofexposurefromthegas
leakwasgreater, therewasagreaterchanceofinitialclinicalill-
nessbeingmild. Aslighdygreaterproportionofseverec.asesin
our cohort were seen as compared to the cases treated in the
railwaycolony. (Seebelow; two-thirds ofourcohortcamefrom
thisgroup.)Incomparisonwiththeinitialclinicalseverityofil-
lness, whenweassessedthecasesatourinstitute,69% hadim-
proved, 4% hadworsened, andthe restwereunchanged.
Table2liststhesequentialpatternsinclinicalsynptomsunder
threecategories. Withsixassessmentsdoneover2yearsonthis
cohort, werestudied68 at 12 months and 87 at24months. The
frequency(percent)ofchestsymptomsislistedasneurologicor
psychosomatic asassessedbyqualifiedpsychiatrists. Psychiatric
testingwasnotdoneatthefirststageasthesubjectswereveryill
and it was perhaps cruel to do prolonged testing immediately
afterthetragedy; thetests werealsonotpossibledueto notob-
taining cooperation in aproportion ofcases.
Respiratorysymptiomsscoresdecreasedat3,6,and 12months
butincreasedsignificantly later. Thecommonestsymptom was
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Table 1. Age-sexdistributionof113MIC-exposedsubjectsandseverity of
illness: originalcohort.
Age, years
Sex Total (%) <20 21-40 41-50 <50
Male 87 (77%) 4 38 28 17
Female 26(23%) 6 19 1 -
Clinical severity of Mild Moderate Severe
initial illness 30 (27%) 57(50%) 26 (23%)
Table2. Sequential patternsinclinical symptoms intheoriginal cohort.
Month (n)
Symptom 0 (113) 3 (79) 6(56) 12 (68) 18(68) 24(87)
Respiratory, %
Cough 98 51 41 72 42 70
Sputum 42 44 36 8 23 48
Dyspnea 97 86 89 97 86 94
Chest pain 69 51 39 48 51 60
Respiratory 2.92 2.32 2.05 2.12 2.82 2.90
score (mean ± ± ± ± ± ±
± SD 1.55 1.34* 1.17* 1.13* 1.20 1.27
Neurologic,%
Muscle 32* 83 75 70 91 90*
weakness
Poor memory 29* 40 25 28 42 59*
Poorconcen- 11 30 12 47 12 8
tration
Tremors 3 25 23 6 10 25
Psychiatrist's - 58 40 40 56 60
assessment
number,%
Bodyache - 8 35 42 24 15
Insomnia - 29 42 42 26 58
Headache - 16 16 30 24 47
Jointpains - 7 12 10 12 51
Apathy - 16 15 12 43 1
Tiredness - 19 15 12 43 -
Giddiness - 14 25 18 0 24
*Significantly improved, p < 0.05
testingwasnotdoneatthefirststageasthesubjectswereveryill
and it was perhaps cruel to do prolonged,testing immediately
afterthetragedy; thetestswerealso notpossibleduetonotob-
taining cooperation in aproportionofcases.
Respiratory symptomsscoresdecreasedat3,6, and 12months
butincreasedsignificantly later. Thecommonest symptomwas
dyspnea on exertion; a paroxymal component was unusual.
These subjects were intermittently given antibiotics andbron-
chodilatorsbylocaldoctors, butdespitethis, thesymptomsper-
sisted. Fromneurologic symptomsspontaneouslyelicted, mus-
cle weakness andpoormemory became more frequent (0.05).
Theeyeproblems(whichweresubsequentlypresentin2-10%)
andabdominal symptoms(seemunrelated)arenotlisted. Severl
moresymptomswerediagnosedbyapsychiatrist. Perhaps some
ofthesewererelatedtoprocedures intheprotractedlegalcom-
pensation case.
Table 3 lists the psychiatric abnormalities as assessed by
psychiatristsandsocialworkers. Table3showsthatonly 19-27%
wereconsiderednormal. Theproportions withpureanxietyor
depressionincreasedover2yearsbutthosewithmixedlesions
decreased (p < 0.05). Hamilton scoring revealedthatthepro-
portions with normal scores for both anxiety and depression
declined over2 years (p<0.05).
Table3. Patterns inpsychiatricabormalities.
Month
Symptom 3 6 12 18 24
Psychiatric assessment
No. studied 60 37 42 63 60
Normal,% 23.3 27 26.2 19 20
Anxiety,% 8.3* 5.4 11.9 25.4* 15
Depression,% 15* 27 21.4 19 36.7*
Mixed,% 53.3* 40.5 40.5 36.5 28.3*
Grading by Hamilton scores
No. studied 48 36 36 48 60
Anxiety,%
None (1-12) 45.8* 38.8 27.7 22.9* 26.6*
Mild(13-24) 20.8 22.2 19.4 52.1 34.4
Moderate (25-36) 33.3 27.7 47.2 22.9 28.1
Severe (36+) 0 11.1 5.5 2.1 10.9
Depression,%
None(1-15) 65.3* 51.4 37.8 45.8* 46
Mild (16-25) 24.5* 21.6 13.5 33.3 34.6*
Moderate (26-35) 6.1 21.6 37.8 16.7 12.7
Severe (36+) 4.1 5.4 10.8 4.2 6.3
*Significantatp < 0.05.
Those with mild abnormalities simultaneously increased.
These assessments also covered memory count, I.Q. assess-
ment, andBender-Gestaltscores. Forthelattertwoscores, the
proportions withnormal scoresincreasedsignificantlyafter 12
months (p<0.05), while for memory count there was no im-
provement.
Table4reportsresultsofpersonalitydysfunctionandpsycho-
social studiesthatwereobtainedafterfillingadetailedprofor-
maandchecking. Theresults showalargeprevalenceofpost-
MICexposureabnormalities. Insixcategoriestherewassignifi-
cantpartialimprovement, bestseenat 18months. Table4lists
increasedprevalencesofabnormalpsychosocialfunctionafter
Table 4. Sequential patterns in personality and psychosocial function in
MIC-exposed subjects.
Month
Assessment 3 6 12 18 24
Personality dysfunction, abnormal %a
No. studied 60 59 72 69 65
Irritability 75 70 72 58 64
Poorconcentration 70 56 67 45* 52
Indecisive 60 46 51 32* 45
Pooradjustment 52 51 47 26* 25*
Unstable relationship 50 46 53 36 40
Emotional lability 45 26 15 2* -
Overdependent 40 42 33 35 46
Hypersensitive 68 49 47 38* 48
Cannotcope with frustration 75 61 72 55* 60
Psychosocial function, abormal relationship,% (pre-MIC,n=91)t
Family 4 62 59 62 44 55
Interpersonal 4 67 49 46 20 26
Social 0 58 54 50 49 44
Job 12 70 73 78 61 74
Marital 6 17 26 29b 18 18
Sexual 1 67 41 55b 54 52
aThese assessments were notdone in some subjects who were not coopera-
tive.
bOmitted in somesubjects (upto 10) as notapplicable.
Pre-exposure status assessed as generally better.
*Significant improvementcompared to 3-month status (p < 0.05).
tPre..MIC and allpost-MIC statusdifferences,p < 0.01 exceptmarital:p <
0.05. Totalpsychosocialstatusat3monthsand12monthscorrelat significandy
toFVC(p < 0.01; r = 0.51 and0.77, respectively) andFEV, (p < 0.01; r =
0.56and0.73, respectively).
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ficantpartialimprovement, bestseenat 18months. Table4lists
increasedprevalencesofabnormalpsychosocial functionafter
MIC exposure. Some assessments were omitted in a few sub-
jects, whereconsiderednotapplicable(e.g.,job, marital). The
total abnormality score at 3 and 12 months correlated signifi-
cantly to FVC and FEVy (forced expiratory volume in 1 sec),
suggestingthattheseabnormalitieswereaconsequenceoflung
functionaldisability. Thesepersistentpsychologic abnormalities
may be secondary toorganic lungdisease.
Radiographic andLung FunctionChanges
Table5 listschestradiographicpatterns. Only2-4% offilms
over2 yearswere readasnormalby ourcriteria. Thepropor-
tionshavingoverinflation, pleural scars, heartenlargement, and
Table5. Serialradiographic patternsintheMIC-exposed(n=113)cohort.
Month (n)
Pattern 0(113) 3 (79) 6(56) 12 (68) 18(68) 24(87)
Normal,% 2 2 4 0 0 3
General abnormalities
Overinflation 15 7 14 0 5 7
Pleuralscars 21 3 10 0 2 6
Consolidation 4 6 0 0 0 1
Enlargedheart 19 3 4 2 3 5
Parenchymal scars - 3 6 4 3 3
Interstitial deposits zonal distribution
1-2 36 25 24 9 36 26
3-4 40 49 48 64 59 51
5-6 24* 26 24 27 5* 20
Type
Linear 82 64 86 92 94 94
Punctate 37 43 28 58 20t 16t
Reticular 27 6 16 14 23 24
Micronodular 27 32 36 14t 3t 8t
Change from0months
Better - 64 66 62 67 58
Worse - 6 20 11 10 12
*Significantly different fromcontrols,p<0.05.
tSignificantly lower,p<0.0S.
consolidationdeclinedby6monthsandlater(p<0.05). Atthe
early stage, only in a few, consolidations responded to an-
tibiotics andinonecasedistinctcalcifiedscarsdevelopedatthe
right base. However, the main changes seen were interstitial
shadows, which were distributed in fewer zones after 12
months; butgenerally 3-4zones were involvedwith linearor
punctatedeposits. Thepunctatedepositswereseenlessoftenat
18and24months, andmicronodularinfiltratesdecreasedat 12
monthsorlater(p<0.05 forboth).
Table6liststhemeantrendsinlungfunctionandbloodgases.
Whileat0and3months,allsubjectscooperatedwithbloodgas
studies, atlaterperiods(notdoneat6months)werestrictedthese
tomoreabnormal subjects. Oxygenuptakeatrestdidnotshow
furtherchangeafter 3 months (Table6).
ExerciseVo2increasedadequatelyat3 months, andthe im-
provementwasmaintained (pairedcomparisonin44 subjects:
1123 ± 280mLatO, 1157 ± 403 mLat3 months,p <0.05).
Initially Po2 dropped significantly with exercise in 39% sub-
jects. Po2 atrestdidnotchange significantly, butPco2 rose at
24 months (p<0.05), and pH declined between 12 and 24
months(p<0.05); COHbandMetHbdecreasedtonearnormal
levelsby3months(p<0.05). Therewasnorelationshipofthese
valuestotheinitial clinical severity.
Table6listslungfunctionsastruevalues. Iftheseareevaluated
as standardized (to age, height, and sex) and compared statis-
tically, theconclusions remainsimilar. Also, ifonerestrictsthe
analysestoacommongroup, thetrends seenareunchanged (it
seemedthatmoreimprovedcasesdefaultedeasily). Thus, FVC
andFEV1 improvedby 12months, thendeclinedlater. ThePEFR
values increased by 12 months and later maintained improve-
ment. MEFR(0.25-0.75)valuesdidnotimprove, nordidMEFR
(200-1200). TherewasasignificantreductionofFEV1/FVC%
by 12monthsthatpersisted. Significantbronchodilatorresponse
wasseeninasmallproportion, whichdidnotseemtoaccentuate
later. Initiallyonly 11.6% showedanimprovementinFEVy (be-
tween 11 and20%)andin8.9% itwasabove20%. At3months,
therespectiveproportionswere7.7and8.8%. Thus, thereseems
Tible6. Sequentiallungfunction trendsinMIC-eposed (n = 113)cohort.a
Month (n)
Measurement 0(113) 3 (79) 6(56) 12 (68) 18 (68) 24(87)
FVC, L 2.05 ± 0.68 2.08 ± 0.62 1.99 ± 0.58 2.68 ± 0.66* 2.91 ± 0.68 2.59 ± 0.66
FEV,, L 1.98 ± 0.67 1.97 ± 0.62 1.93 ± 0.57 2.24 ± 0.60* 2.26 ± 0.59 2.14 ± 0.62
VC, observed/
predicted 70.3 ± 16.9 70.1 67.3 93.3 99.9 87.9
PEFR, L 362.3 128 403 ± 123 412 ± 100 444 ± 105 469 ± 90* 467 ± 106
FEVI/FVC% 97 ± 4* 96 ± 5 97 ± 6 83 ± 8* 79 ± 9 83 ± 10
Bronchoreversibility
FEV,, % increase 7.2 ± 10.2* 4.8 ± 8.1* 5.1 ± 5.9* 5.4 ± 7.5* 3.8 ± 5.3* 5.8 ± 8.9*
MEF0.25-0.75' L/min 200 ± 82 213 ± 93 207 ± 70 170 ± 79 144 ± 76 150 ± 72
MEFR200-1200, L/min 234 ± 112 256 ± 116 249 ± 96 265 ± 109 272 ± 109 241 ± 118
Gas exchange
MV, L 8.45 ± 3.27 9.45 ± 2.24 10.29 ± 1.84 9.96 ± 2.16 10.45 ± 1.49 8.94 ± 2.54
Vo2atrest, mL 198 ± 58* 227 ± 50* 218 ± 52 236 ± 45 243 ± 43 244 ± 102
Po2, mm(n) 100.9 ± 12.7 88.8 ± 20.3 - 94.1 ± 12.4 (22) 93.8 ± 10.6(18) 94 ± 9.8 (16)
Pco2, mm 33.3 ± 3.7* 33.3 ± 4.6 - 33.6 ± 3.1 34.1 ± 1.4 38.2 ± 4*
pH ' 7.49 ± 0.05* 7.46 ± 0.06* - 7.43 ± 0.04* 7.42 ± 0.04 7.39 ± 0.03*
COHb(n) 5.97 ± 11.1*(70) 2.28 ± 1.43*(71) - 2.26 ± 1.48 (58) 2.29 ± 1.29 2.28 ± 1.48
MetHb 1.76 ± 0.74* 0.88 ± 0.73* - 0.66 ± 0.27 0.40 ± 0.27 0.38 ± 0.17
Abbreviations: FVC, forcedvitalcapacity; FEVI, forcedexpiratoryvolumein 1 sec; VC, vitalcapacity; PEFR, peakexpiratory flowrate; MEF, maximumex-
piratory flow; MEFR, maximumexpiratory flow rate; MV, minuteventilation, COHb, carboxyhemoglobin; MetHb, methemoglobin.
aSimilarresults ifage, height, and sex are standardized.
*p < 0.05.
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FIGURE 1. Micrograph showingthickenedvesselwithmedialmuscularhyperplasiaandendothelialhypertrophy. Bronchial lumenisfilledwithinflammatorycells
with desquamation. There ispatchy round-cell infiltration around lung tissue.
FIGURE 2. Micrograph showing mucinous impaction inbronchiole with interstitial alveolitisandperibronchial round-cell infiltration.
tobe noincrease in "asthmatic" tendency afterMIC exposure.
In 10 cases tested for graded histamine airway reactivity
(0.03-16mg/mLconcentration) at3 and6monthsusing stand-
ardtechniques, 5 reactedat 1 mg/mLconcentration(PC20[pro-
vocativeconcentration: 20% decreaseinFEVIJ)while3 showed
PC20 at 5 mg/mL. The changes in DMBC (direct maximal
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breathing capacity), RR (respiratory rate), or MV (minute ven-
tilation) wereinsignificant. In four cases with severedisability,
there were no abnormalities of response to graded hypoxia.
When the initial FVC and FEVy were correlated to respiratory
symptom scores, there was a very significant relationship (FVC:
r = -0.76; FEV,: r = -0.79; postbronchodilator FEV1: r =
-0.85). Thus we concluded that our clinical symptomatology
was reflected in the functional values measured.
Pathologic and Immunologic Results
Pathology and immunology are reported in detail elsewhere
(2,4). Lung histology inclosed needle (n =5) biopsies showed
collagenous tissue. In three open biopsies, mild septal and
pleural fibrosis, perivascular, and peribronchial fibrosis, active
bronchitis, inflammatory interstitial exudate, distended bron-
chioles filledwith mucinous material with interstitial scarring,
and muscular-thickened vessels were seen. (Figs. 1 and 2).
Fiberoptic bronchoscopy findings (2) (donewithin4weeksin 8
cases) showed distorted airway lumenand mucosal swelling in
all, lymphoidhyperplasia in 3, ulceration in2, andpatchy con-
gestion in 3. Bronchoalveolar lavage (BAL) done in 14 cases
showed hightotal cell countinall withneutrophil excess (n = 9),
macrophageincrease (n = 2), eosinophil excess (n = 1)andlym-
phocytosis (n = 1).
Immunologic studies done in99 subjects collected atintervals
are shown inTable 7. Total IgElevels showed insignificantly high
levels initially, which later declined. Preliminary studies prov-
ed that antibodies specific to MIC (as GSA or HSA) were
detected by ELISA inhibition assays, and these did not cross-
react to other isocyanates orconjugates. Thus, MIC-KLH was
shown to inhibit antibody specific to MIC. Upon storage, the
sera, due to lag fromdelay insending samples toUnited States,
did notdecay (which mayhave affected theirevaluation). Mean
RAST IgE binding revealed levels from 2.31 ± 2.95% ((0
months) to 3.68 ± 4.95% (12months). Whilethese wererelated
closely to totalIgE levelsvalues, both wereunrelated toclinical
orfunctional changes seen. In 11 cases, MIC-specificantibodies
were detected (IgM, 7; IgE, 4; IgG, 6) on several occasions. in
one case antibodies weredetected 1 yearafter exposure, but in
most subjects, these were found in a sample taken within 3
months. In 10subjects withclinically adequatedata,4had severe
and6hadmoderate initialillness. Radiographically, oneto three
zones showedinterstitial deposits in three subjects andfourtosix
zones in seven cases. Itappeared thatthose ill initially butwho
improved later developed positive antibodies. This finding of
MIC-specific positive antibodies, albeit with low titers, has
crucial medical and legal significance for a cause-effect rela-
tionship.
Table 7. Immunologic results inMIC-exposed (n=99) subjects.
Month (n)
Measurement 0 (63) 3 (79) 6 (66) 12 (96) 18 (25) 24(17)
Total IgE, IU 1230± 894± 667± 711± 618± 973±
1411 979 832 772 678a 671a
RAST binding, 2.31± 2.33± 2.74± 3.68± - -
IgE 2.95 2.65 3.07 4.95
Control, IgE (n) - - 424± 305±
1198 (12) 1016 (39)
aMeasurements restricted to abnormals.
TIble& GraphictrendsinMIC-exposedsubjects(n = 113)withacceptable
patterns.
Pattem, n(%)
Improving
and then
Parametersa Stable Improving Worsening worsening Fluctuating
Clinical dys- 45(48.4) 22(23.7) 7(7.5) - 19(20.4)
pnea(93)
Cough(90) 16(17.8) 8(8.9) 13(14.4) 8(8.9) 45(50)
Sputum(91) 21(23.1) 14(15.4) 11(12.1) 10(11) 35(38.5)
Lung 35(38.0) 26(28.3) 6(6.5) 0 17(18.5)
signs(92)
X-ray 5(5.5) 19(20.9) 19(20.9) 13(14.3) 35(38.5)
zones(91)
Lung function
FVC(92) 13(14.1) 26(28.3) 0 22(23.9) 31(33.7)
FEV,(91) 31(34.1) 26(28.6) 1(1.1) 14(15.4) 19(20.9)
Bronchoreversiblity,
FEVy (85) 74(87.1) 4(4.7) 7(8.2) 1(1.2) -
MEFR 13(14.8) 5(5.7) 37(42.1) 18(20.4) 15(17.1)
0.25-0.75(88)
MEFR 17(18.7) 19(20.9) 9(9.4) 17(18.7) 29(31.9)
200-1200(91)
PEFR (91) 12(13.2) 50(55.0) 2(2.2) 5(5.5) 22(24.2)
MV (91) 27(29.7) 12(13.2) 15(16.5) - 15(16.5)
Vo2 (91) 6(6.6) 4(4.4) 32(35.2) 9(9.9) 40(44.0)
COHb (77) 11(14.3) 42(54.6) 8(10.4) - 16(20.8)
MetHb (85) 2(2.4) 60(70.6) 2(2.4) - 21(24.7)
Abbreviations: FVC, forcedvital capacity; FEV,, forced expiratory volume
in 1 sec; MEFR, maximumexpiratory flow rate; PEFR, peakexpiratory flow
rate; MV, minuteventilation; COHb, carboxyhemoglobin; MetHb, methemo-
globin.
'Total number inparentheses.
Defaults andRelationshipto Clinical and
Functional Sequence
Though we had planned a full follow-up for 2 years in six
phases, wedidnotsucceedfully. At 1 and2 years, wefollowed
68 and 87 subjects. Ofthese, those who were assessed func-
tionallyandclinicallyonatleasttwosubsequentoccasions (in-
cludingthelast) wereincludedintheregular(81)cohort. When
thesewerecompared, itwasseenthatdefaulters (32)wereslight-
ly less abnormal initially and improved more. Onpreliminary
analysis, itwasseenthatwhilemanyshowedimprovementupto
12monthsanddeterioratedlater, therewereotherpatterns, e.g.,
TAble9. Meantrendsinlungfunctionintheregularcohort (n = 81).a
Month (n)
Measurement 0(81) 3(69) 6(55) 12(69) 18(65) 24(81)
FVC,L 2.02 2.02 1.96 2.66 2.84 2.59
FEVJ,L 1.93 1.95 1.91 2.23 2.26 2.14
FEV,/FVC,% 95.5 96.1 75.2 83.1 79.8 82.3
Bronchorever 5.7 5.9 5.1 5.5 3.8 5.8
sibility, %
MEFR0.25-0.75, 194 210 204 168 144 147
L/min
MEFR200-1200, 227 253 248 263 272 242
L/min
PEFR, L/min 363 400 410 445 471 466
MV,L/min 8.35 9.52 10.31 10.02 10.46 8.85
Po2, mm 101.4 93 - 94.1 93.8 94.1
Pco2, mm 33.5 31 - 33.5 34.1 38.3
pH 7.49 7.47 - 7.43 7.39 7.38
aSDsomittedasthey weresimilar tothose listed inTable 7.
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Table 10. Sequential trends foranxiety, depression, and IgE levels in the e.g., cough and dyspnea show different trends, as do FVC,
regularcohort(n = 81).a PEFR, and MEFR (0.25-0.75). The trends for COHb and
Month (n) MetHb showed only large improvements. For developing a
3 (50) 6(43) 12(50) 18(40) 24(58) model, wethoughtthistobeagoodprimarystep. Afluctuating
Hamilton scores behaviorwasseenin20-50% ofsubjectsinvariousparametres
Anxiety 15.3 19.5 19.6 19.1 20.1 (we did notanalyze changes in bodybox or flow-volume loop
Depression (n)b 12.1 (53) 16.5 (52) 17.2 (60) 14.3 16.3 valuesaswehadnotdonethesetestsinitiallyinmany subjects).
IcIF iinitc I'A P%C12 Qq(A '7RQ AAR 1gC units 1.JJ YJV 107 WO0
aSDs similarto values for thecohort in Table 6.
bn = 48 at 0months. Results inRegular Cohort
stable, improving, worsening, fluctuating, and improvment The results in the regular cohort (n = 81) are presented in
followed by deterioration. The general behavior was that Tables 9 and 10. Table 9 shows that despite the data being
25-30% wereconstantly improving andone-halfbelonged tothe restricted to 81 cases, the trends for various parameters are
last category. similar;thesignificanceofdifferences arealsothe same. Table
Wedecided tolookatthisproblemindetailfor 15 parameters. 10gives results fordepression, anxiety scores, andIgE. Again
Inthose where follow-updata showed acleartrend, wegraph- thechanges are similar to those intheoriginal cohort.
ically derivedtheirpatterns individually; theresults areshown When distribution ofclinical chest symptoms and signs are
inTable8. Itis seenthatall parametersdonotchangeidentically, compared in six phases along with severity of initial clinical
lTble 11. Correlation coefficientsin the total cohort at theinitial stage.
Cough Sputum Dyspnea FVC FEV, MEF25 MEF200-1200 PEFR Vo2 DMBC
Sputum 0.52* - 0.39t -0.22 -0.26* -0.24* -0.25 -0.21
Dyspnea 0.39t 0.28* - -0.16 -0.16 -0.16 -0.15 -0.13
Weight - - - -0.27* -0.27* -0.22 -0.33t 0.41t 0.27t
Lung signs 0.27* - - -0.27 -0.26 - - - -
Cough - - - . 0.26* - -0.30* - -
FVC - - - - 0.98* 0.81t 0.81t 0.80t 0.33t 0.88t
FEV, - - - - - 0.85t 0.83t 0.82t 0.32t 0.92t
MetHb - - - - - 0.26* - 0.26*
P02 - - - - - 0.28* - - -
Vo2 - - - - - - 0.29* 0.38t -
Reversibility - - - - - - - 0.40t
MV - - - - - - - - 0.74t _
Abbreviations: FVC, forcedvitalcapacity; FEVI, forcedexpiratory volume in 1 sec; MetHb, methemoglobin; MV, minuteventilation; MEF, maximumexpiratory
flow;, PEFR, peak expiratory flow rate; DMBC, direct maximal breathingcapacity.
*p<0.05. *p0.01.
Table 12. Correlation coefficients in thetotalcohortcoveringsixphases over2 years.
FVC MV IgE FEV, MEF25 MetHb CoHb Cough Dyspnea Lung signs Weight Sputum X-ray
Sputum - - - - - - - 0.58t 0.26t 0.17t - - -
Dyspnea - - - - - - - 0.19t
Lung signs - - - - - - - 0.19* - - - 0.17t
FVC - - - - - 0.22t - - - 0.26t 0.21t - 0.19t
FEV, - - - - - 0.17t 0.31t 0.23t - 0.16*
MEF25 - - - _ - - - 0.16t 0.19t 0.15* 0.19t. - -
Lung over-
inflated - 0.16* - - - - - - - - 0.20t -
COHb - - - - - 0.27t - 0.28t - _ - 0.21*t
MetHb
P02 - - - - 0.27t 0.28t - 0.20* 0.20* - -
Pco2 0.37t - - 0.21* - 0.45t 0.23t - - -
pH - - - - - - - - - - - - 0.29*
MEF200 - - - - - - - 0.18t 0.19t 0.19t 0.29t 0.12* -
DMBC - - - - - - - - - - 0.26* - -
MV - - - - - - - - - - 0.14* - -
Vo2 0.22* 0.63t 0.16 - 0.24t 0.19* - - - 0.36t - -
Depression 0.22t - - 0.22t 0.21t - - 0.26t 0.28t 0.17*
Anxiety 0.18t - - 0.18t 0.18t - - 0.25t 0.31* 0.16t
PEF - 0.14* - - - 0.20* - 0.13* - 0.24t 0.34t - _
Reversibility 0.20t - - 0.20t 0.18t - - - 0.26t - _ -
IgE - - - - - 0.30t - - - - - - -
Abbreviations: FVC, forced vital capacity; MV, minute ventilation; FEV,, forced expiratory capacity in 1 sec; MEF, maximum expiratory flow; MetHb,
methemoglobin; CoHb, carboxyhemoglobin; DMBO, direct maximal breathingcapacity; PEF, peakexpiratory flow.
*p<0.05
p<0.01.
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illness (nottabulated), thetrendsaresimilartothetotalcohort.
Moreolderfemales sufferedgreaterillnessinitially,butlaterthe
behavior in both sexes was similar. Therefore, weworked out
trends in correlation coefficients (as a guide to regression
analyses)onthetotalcohort. Thesewereworkedoutonallpossi-
bleparameters insixphasesindividuallyandtogether, butresults
onmoresignificantvaluescoveringallphasesarelistedinTables
11 and 12.
Intercorrelation overTwo Years
Functionalparameterswerecloselyinterrelated. Attheinitial
stage(Table 11), cough, sputum, anddyspneaaremoderatelyin-
terrelated, along with abnormal lung signs (but not overinfla-
tion). SputumissignificantlyrelatedtoFEVI,MEFR(0.25-0.75),
andMEFR(200-1200). Dyspnea, however, isnotsignificantly
correlatedtolungfunctions, butcoughiscorrelatedtoFEVy and
MEFR (200-1200). Lung signs correlated to FVC and FEVy,
while MetHb correlated to MEFR (0.25-0.75) and PEFR and
Po2to MEFR(0.25-0.75).
Table 12correlatesthecoefficientscoveringallsixphases. Due
to larger volumes ofdata, several more correlates now seem
significant. Thus, chestsymptomsandsignsareinterrelated, as
arelungfunctions, bloodgases, DMBC, Vo2, scoresforanxiety
anddepression. IgE levels correlatedto MetHbvalues.
From theseresults weconcentratedonthefollowing param-
eters in modeling for a sequential behaviour in the regular
cohort: a) clinical: cough, dyspnea; b) function: FVC, MEFR
(0.25-0.75), PEFR, Vo2, Pco2; c) X-ray zones anddepression
score.
Figures 3-8 delineate the types ofpatterns on six selected
parameters ontheregularcohortashomogenizedcurvesexten-
ding beyond 24 months. Thus, if an individual's progress is
knownduringthefirst24monthsbyactual(atleastthree)obser-
vations, hisfuturecoursecanbepredictedbyourgraphicdisplay.
Table 13 also gives the actual proportions on each ofthe six
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parameters. Fordyspnea, therewerefourpatternswith45.7% as
stable (Fig. 3). For FVC, the major pattern (offour) was fluc-
tuating (35.8%), for MEFR (0.25-0.75), the major pattern (of
five)seenwasworsening(40.7%), followedbyworseningafter
early improvement (24.7%) (VE75 [expiratory flow at 75% of
VC] from FV loop tends to behave similarly). For PEFR, the
main pattern was improvement (53.1%) (as also for Vo2,
39.5%). Fordepressionscore,themainpatternwasfluctuating.
Thus, ontheregularcohortwepredictedchangesinsixparam-
eters fairly accurately.
Table 14showsthefurtherdevelopmentofthisconceptbydo-
ing mutifactorial analyses. Analyses wereconductedon seven
parameterslistedforfactor 1 atallsixphasesandlateronlyfor
thefirstandsixthphases.Thus, asstep 1, six(Eigenvalue)equa-
tionswerederivedandas step2 factorscores as listed inTable
14werederived. Corresponding factorscores forsixvariables
withlargevaluesinthefirstequationandsmalleronesinthese-
condequationwereworkedout. Thenthefactorialscorefortwo
factors and severity scores were obtained, accounting for
variance. Eigen values for two sets ofvariables were derived.
WhenFVC, MEFR(0.25-0.75), andPEFR, whichareclosely
related, are accounted for in the first effort, correlation with
cough, dyspnea, PCO2, and X-ray zone become significant
(Table 14). Byvarianceanalysesinthesetwoattemptswecould
explain a variance of36.5 and 15.9%, respectively (Table 14).
Thus,usingsevenparameters, ourmodelcouldexplainbehavior
of52.4% (amodelwithmoderateaccuracy). Ifonecorrelatedthe
clinical severity, themodelpredictionis significantlycorrelated
(p < 0.01). Wevalidatedourmodelbyworkingontheotherfour
phases. Asthebehaviorover2yearsofMIC-exposedcaseswas
not different by age/sex, we thought this multifactorial model
couldbeappliedtoothercohortsorBhopalcitypopulationalso.
Table 15 describes theseattempts totransferthisbehaviorto
therailwaycolonycohort. Itdescribestheage-sexdistribution
accordingtotheseverityofinitialclinicalillness seenfromthe
actualrecordsoftreatedcases scrutinizedandclassifiedby the
seniorauthor. Atotalof1640subjectsweretreated, andin 1617
cases, datawereadequateforsuchclassification. Table 15reveals
U- ,,
0 3 6 2 I-8
TIME INTERVAL
Z4
- IMP. a DECREASING
IMPROVING
- FLUCTUATING
e-- STABLE
0 3 6 12 18 24
FIGURE 3. Patternsobservedforbreathlessness (grades)onverticalaxisand
timeinterval inmonthsonhorizontalaxis. Theactualproportions aregiven
inTable 13. Thecurvesarehomogenized andprojectedbeyond24monthsof
actual observation.
FIGURE 4. Similarpatternsofforcedvitalcapacity shownnmilliliters onver-
ticalaxisforthemonthofmeasurement. Notethatthebehaviorisdifferent
fromthatinFigure 1.
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FIGURE 5. Patterns for maximum expiratory flow rate (0.25-0.75) shown as
liters/minuteonthevertical axis forthe monthofmeasurement. Theimprov-
ing group also shows only a small increase.
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FIGURE 7. Patterns for °2 uptake shown as milliliters/minute on the vertical
axis for the month ofmeasurement. There are many variations.
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FIGURE 6. Patterns forpeakexpiratory flow rate shown as liters/minute on the
vertical axis for month ofmeasurement. Generally, all groups show some
improvement.
that inthe railway colonycohort, there are agreater numberof
youngersubjectsand morefemales,alongwithanexcessofmild-
ly affected cases. On comparison for these behaviors, in this
population and our regular cohort, we found no statistical dif-
ferences. Thedifferences we looked forweretheclinical, func-
tional, and psychologic parameters.
Table 16givesadditional dataonage, sex, typesofclinical in-
itial symptoms, andseverityofillness. Theadmittedgroupcon-
sistedofalargerproportion ofmoderateandseriously illcases.
In alargemajority, the initial illnesslasted upto2weeks andin
30.3% itpersisted tobecomechronic. Inthoseadmitted, theill-
ness, perhaps due to treatment, seemed to have remitted more
often.
Table 17 details results by applying our factorial model to
predict in three severity categories the clinical behavior for 2
FIGURE 8. Patterns ofHamilton depression scores. Each ofthese parameters
seem to have peculiar variations.
yearsontherailwaycolonycohort. At0months, oldersubjects
hadmore severeillnesses. Theproportion inthemildcategory
increasedlater, particularly atyoungerages. Butforallages, the
moderatecategorypredominates inlaterperiods, particularly at
olderages. Thismeansthataftersomeimprovement (which was
greaterinyoungersubjects), thereisenhancementofsymptoms
andtheir severity over 2 years.
Table 18 projects age-standardized (to account for any dif-
ferences) sequential behavioroffourfunctional parametersand
depression as per our model on the railway colony cohort.
Behavior is similar to our regular cohort and broadly shows a
fluctuatingcourse; forFVC, maximal improvementinallthree
groups is seenat 18months(irrespective ofinitial severity). For
MEFR(0.25-0.75), thereis agradualreduction over24months
to a level thatis slightly lower inthe severe groupat24 months
(thoughdifferences arelargeinitially). ForPEFR, thetrendsare
similartoFVC, butwith nodifferencesbetweenthreegroupsof
clinicalseverityofillness. ForV02, similartrendsareseen. For
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Table 13. Frequency ofpatterns in progress on six parameters
inregularcohort.
Pattern, n()
Improving,
Parameter Worse Stable Improving stable Fluctuating
Breathlessness 20(24.7) 37(45.7) 5(6.2) - 19(23.5)
FVC, mL - 8(9.9) 23(28.4) 21(25.9) 29(35.8)
MEFRO25-75, L 33(40.7) 11(13.6) 3(3.7) 20(24.7) 14(17.3)
PEFR, L 1(1.2) 10(12.4) 43(53.1) 5(6.2) 22(27.2)
02uptake, mL 4(4.9) 5(6.2) 32(39.5) 16(19.8) 24(29.6)a
Hamilton depres-
sionscore(n=67) 15(18.5) 12(14.8) 10(12.4) 8(9.9) 22(27.2)
Abbreviations: FVC, forcedvital capacity; MEFR, maximumexpiratory flow
rate; PEFR, peak expiratory flow rate.
aIncludes worse and improving.
Table 14. Model building on regularcohort forbehavior
andmultifactorial analysis.
Factor 1 Factor2
Factor score: coefficient
FVC 0.907 0.147
MEFR 0.25-0.75 0.915 0.114
PEFR 0.913 0.176
Cough -0.365 0.621
Dyspnea -0.273 0.751
Pco2 0.201 0.291
X-ray zones -0.074 0.352
Correlation of -0.242* -0.227*
severity index
Eigen value 2.917 1.273
Percent variance explained 52.4
Abbreviations: FVC, forced vital capacity; MEFR, maximumexpiratory flow
rate; PEFR, peak expiratory flow rate.
*p<0.01.
Table 15.Age-sexdistributioninrelationtodinicalseverityofinitialillness
in railway colony patients (1617cases).
Clinical illness
Mild Moderate Severe Total
Age, years Male Female Male Female Male Female Male Female
6-19 22+67 18+76 35+52 15+50 5+5 3+0 186 162
1-19(%) (47.8) (58) (46.8) (40.1) (5.4) (1.9)
20-44 319* 187 230 136 27 9.0 576 332
(%) (55.4) (56.3) (39.9) (41) (4.7) (2.7)
45+ 134 32* 134 31 22 8,Ot 290 71
(%) (46.2) (45.1) (46.2) (43.7) (7.6) (11.2)
aGroup includes subjects upto 5 years old.
tSignificant difference between sexes,p<0.05.
*p<0.001 for age differences in females.
depression scores, it is seen that in all three groups the scores
worsenupto 18monthsandthenstabilize(slightly lowerinmild
grouponly).
As ourmodel was derived on a small cohort basedon0- and
24-monthdata, datawerevalidatedforallsixphases; ourattempt
toprojectbehavioroftherailwaycolonycohortwassuccessful.
Asthere were no significantdifferences insequential behavior
by ageorsex, weappliedthis furthertotheaffectedBhopal ci-
ty population.
Table 19givestheage-sexdistributionandclinicalseverityof
illness intheBhopalcitypopulation. Thiswasderivedfromafull
censusoftheinnercityandarandom, stratifiedsampleofthree
variablyaffectedcommunities. AsperdesignoftheIndianCoun-
cilofMedicalResearch (ICMR), thecohortwastoberepresen-
tativeofthegeneralcity. Heretheage-sexdistribution isspread
Table 16. Clinical patternofsymptoms intheinitialillness
intherailwaycolony.
Male, %
Female, %
Age, years
0-5,%
6-19,%
20-44,%
45+,%
Clinical symptoms
Respiratory,%
Eye,%
Gastrointestinal, %
General,%
Neurological,%
Cardiac,%
Severity
Mild,%
Moderate,%
Severe,%
Total admitted
Mild
Moderate
Severe
Duration ofinitial
illness, weeks
1
2
3
4
Chronic
65.7
33.7
6.0
15.8
55.3
22.9
89.0
87.1
35.1
16.8
15.7
1.3
55.3
41.8
4.8
45.3
47.0
7.7
Total
39.1
27.5
10.5
22.7
30.3
No. admitted
31.7
39.4
12.7
16.0
17.7
Table 17.Sequentialprojectedbehavior inclinicalswverityofillnessinrailway
colonycohort (n =1617).
Month
Age, years(n) 0 6 12 18 24
1-19 (348)
Mild,% 52.6 74.4 37.4 37.4 18.7
Moderate,% 43.7 21.8 58.9 58.9 77.6
Severe,% 3.7 3.7 3.7 3.7 3.7
20-44 (908)
Mild,% 55.7 49.2 32.7 45.2 20.5
Moderate,% 40.3 48.8 65.3 52.9 71.3
Severe,% 4.0 2.0 2.0 1.9 8.2
45+ (361)
Mild,% 46.0 39.9 12.2 28 6.9
Moderate,% 45.7 51.8 72.6 68.7 85.9
Severe,% 8.3 8.3 15.2 3.3 7.2
evenly, anddistributionofclinicalillnessgradesmoreequitably.
Whilethereareseveralsignificantdifferencesbetweenthethree
populations (ourregular, railwaycolony, andtheICMRcohorts),
asthecourseofMIC-induceddiseasedid not seemtodifferby
ageorsex, wedonotthinkthesedifferenceswouldinvalidateap-
plicationofourpredictedmodeltothegeneralcitypopulation.
Table20givesprojectedage-sexstandardized(toaccountfor
significantdifferences)sequentialbehavioroffiveparametersfor
theBhopalcitypopulationover2years. Thus, forthreegrades
ofclinicalillness, thebehaviordoesnotappearsignificantlydif-
ferent(thereforelistedseparately inthreegroupsonly forFVC).
The patterns ofMEFR, PEFR, Vo2, and depression are also
essentially similar to the railway colony cohort. Table 20 also
showssomerelevantdataonabnormallungsymptomsasobserved
at 3 months and fordeaths/1000 at 3 months and 2 years in the
threezonesofclinicallyaffectedgradesofcitypopulation. Itcon-
firms thatthree zones ofdifferently affected degrees ofillness
show different morbidity.
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Table 18 Projectedage-standadedsequential behaviorofBhopalrailway
colony patients.a
Month
0 3 6 12 18 24
FVC, L
Mild 2.02 2.05 2.01 2.66 2.78 2.59
Moderate 1.98 2.02 1.98 2.63 2.76 2.56
Severe 1.96 2.01 1.97 2.63 2.78 2.57
MEFRo.25075 L/min
Mild 197.5 214.5 205.3 173.7 163.6 156.3
Moderate 193.5 210.3 203.4 170.1 163.4 154.5
Severe 189.8 208.4 201.2 166.8 157.2 152.4
PEFR, L/min
Mild 344.4 376.8 404.9 433.8 458.7 453.7
Moderate 338.7 376.4 402.4 429.9 457.8 451.2
Severe 341.5 391.5 406.0 435.6 464.3 457.5
Vo2, mL
Mild 190.5 200.8 204.4 227.6 242.8 228.3
Moderate 189.8 221.0 206:1 228 2.43.8 227.2
Severe 192.9 223.2 212.3 229.7 246.9 229.8
Hamilton depression score
Mild - 12 17 15 17 14
Moderate - 12 17 15 15 15
Severe - 11 16 16 15 16
Abbreviations: FVC, forced vital capacity; MEFR, maximumexpiratory flow
rate; PEFR, peak expiratory flow rate.
aValues are expressed as means.
Table 19. Age-sex distribution in relation to clinically affected grades in
Bhopalcity population.
Clinical illness
Mild Moderate Severe Total
Age, years Male Female Male Female Male Female Male Female
0-24 5663 5414 11013O 10236* 8238 7604 24914 23254
(%) (22.7) (23.3) (42.2) (44) (33.1) (32.7)
25-44 2691 2369 4840t 4164* 3975t 3244 11506 9777
(%) (23.4) (24.2) (42.1) (42.6) (34.5) (33.2)
45+ 1360 1178 2585k 2126 1793t 1528 5738 4832
(%) (23.7) (24.4) (45.1) (44) (31.2) (31.6)
*p<0.0.
tp< 0.05.
tp<0.001.
Table 20. Projected (age-sex)standardized sequential behaviorofBhopal
city subjects.
Month
0 3 6 12 18 24
Mean FVC, L
Mild 1.84 1.92 1.91 2.48 2.57 2.44
Moderate 1.85 1.93 1.92 2.49 2.79 2.45
Severe 1.84 1.92 1.92 2.49 2.58 2.45
Total 1.84 1.92 1.92 2.48 2.65 2.45
Mean
MEFR025-075, L 182.2 200.5 198.8 163.6 174.7 153.7
PEFR, L 304.8 332.6 382 400.2 439.3 425.7
Vo2, L 178.4 214.6 194.1 220.1 240.6 210.4
Depression score - 10 17 13 15 14
Lung abnor-
malities, % Mild Moderate Severe
3 months 1.83 3.49 2.59
1 year 0.90 2.88 7.71
Death rates/1000
3 months 4.21 6.37 11.21
2 years 4.93 9.03 14.13
Abbreviations: FVC, forced vitalcapacity; MEFR, maximumexpiratory flow
rate; PEFR, peakexpiratory flow rate.
Wemay conclude thatthemodel developed onourcohort of
113 subjects could be applied to theBhopal city population for
judging the sequential behaviorofMIC-induceddisease.
Discussion
As our findings up to 6months havealready been published
(1-3), it is fair to state that our earlier evidence ofinterstitial
restrictivelungpathologywithsmallairwaydiseaseisconfirmed.
The airway component seems to haveprogressed, leading to a
fluctuatingcoursewithpersistingdisability. Wefoundpersistent
flow rateabnormalities, particularly forV(E75) (Eindicates ex-
piratory flow rate; 75 indicates expiratory flow rate at 75% of
VC). For V(IP) (IP, inspiratory peak flow rate), V(I50) (I in-
dicates inspiratory flow rate; 50indicates inspiratory flow rate
at50% ofVC), andV(I75)theimprovementwasmaintained, and
forV(EP)(expiratorypeakflowrate),V(E75), andV(E50)there
wasasignificantdeclineafter 18months. Therewerealsoper-
sistentabnormalities offlow-volumeloop (3).
Studies done by Alarie et al. (5) indicate that severe airway
obstructionpersistsafterasingleMICexposure (37 ppm for 3
hr)andrecoveryfrompulmonaryeffectsisvery slow. Recovery
fromMICwasconsideredtobeslowerthanfromH2SO4,toluene
diisocyanate, andwoodsmoke(5). Alarieetal. claimedthatthe
recoverypatternwassimilartothatfollowingexposuretosmoke
from polyvinyl chloride (7). They found VE (expired minute
volume)particularlytobereduced, andVT (tidalvolume) and
respiratory rate did not increase after MIC exposure (5). The
type ofFV loop abnormalities we reported (3) were similar to
those seenby Alarie etal. (5).
Alarieetal. alsodidnotfindacyanidelikeeffect (5) after37
ppmofMIC. Inviewofthecontroversyofthecyanidelikeeffects
(e. g., acommon complaintofpersistentmuscle weakness) in
Bhopal subjects, this may be important. While we have found
evidence of rise in COHb and MetHb initially, possibly at-
tributable to effects ofbreakdown products of MIC, the psy-
chosomatic symptoms ofthe typediscussed earlier seem tobe
correlatedtoorganiclungdisability. Asorganiclungdamageis
notknowntooccur inchroniccyanicepoisoning, wethinkour
sequentialresultsalsoprovideevidenceagainstsuchatherory.
Isocyanateshavebeenassociatedwithoccupationalasthma(8).
Our results show, along with chronic small airway disease,
evidenceofrestrictivelungdisease(1,2). Thesechangesmaybe
similar to those observed by Charles et al. (9). What was not
known in earlier studies, for MIC-induced disease, was its
chronic fluctuating course, for which our follow-up data and
model provide evidence.
Schwetz et al. (10) found that 1-3 ppm MIC exposure 6
hr/dayfor4daysinmiceresultedinasignificantnumberofdead
fetuses atbirth and asignificantdecrease inneonatal survival.
In the railway colony cohort, there were frequentspontaneous
abortions (reportedalsoinexposed areasofBhopal), butthere
wasnoevidenceofincreasedfetalabnormalitiesexperimental-
ly (10) or inthecity population )11).
Otheraspectsofimmunologic, mutagenic, andgenotoxicef-
fects due to MIC have been studied by Deo et al. (12). These
stueiesrevealed(onasimilargroupof67exposedand 15control
subjects) minorchromosomalaberrations, low responsiveness
of lymphocytes to phytohemagglutinin delay in cell cycle, in-
crease in T-lymphocytes, and lowering ofsisterchromatid ex-
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changes. However, such abnormalities were inconsistent and
minor; thisisconfirmedbyTiceetal. (13). TheyfoundthatMIC
exposure for4daysresultedinasmall increaseinchromosomal
aberrations andsisterchromatidchanges; butnogenotoxicityor
mutations werefound(14). Similartoourfindings, specifican-
tibodies have been reported after TDI occupational exposure,
whichshowedafluctuating, increasing, ordecliningcourse(15).
Bucheretal. (16)observedgranulomatous inflammationwith
persistent lungdamage, intraluminal airway fibrosis, andbron-
chiolitis aftera2-hrexposureto MICinrats(17k. Theirstudies
on repeated exposure to 1-6ppm MIC did notresult in signifi-
cantdirecteffects onnonrespiratory tissues (18). Ourobserva-
tions conform to this pattern and both corroborate pesistent
pulmonary damage.
Andersson etal. (19) havepresented some data from Bhopal
community studiesthatindicatedvariations inmorbidityaccord-
ing to wind direction. Thus, the railway colony, situated
southeastofthefactory, sufferedahighmortality. Ourfollow-up
dataindicatesthataffectedsubjectswithvaryinginitialseverities
ofillness have a similar course.
Fedde et al. (20) reported low Po2, increased metabolic aci-
dosis, tissue hypoxia, and increased ventilation-perfusion im-
balance due to bronchiolar obstruction after a high exposure
(240-628ppm)ofMICfor 15 min. Ourfindingsofearlyhypoxia
andlaterofsmallairwayobstructionconfirmtheirdata;however,
withinthefirstfewdays, therewasrespiratory alkalosis, butnot
hypercapniaand acidosis. Several advanceshavebeenmade in
understanding MIC-induced disease since the first article by
Kimmerle and Eben (21). With exposure at23 ppmMIC, they
found heavy breathing, lung edema, and irritiation ofmucosa
(21).
Becauseofthecontinuedwideuseofisocynates, theremaystill
belargeinterest intheirsystemictoxicity. Inastudyof783cases,
2-4 months after exposure to MIC, Rastogi et al. found that
females were more seriously affected (22); although major
change in lung function was restrictive, obstruction was notic-
ed in some. Inanotherpaperfromthisgrouponepidemiologic
data (23) in a study of 1109 subjects, most showed respiratory,
cardiovascular, abdominal, and skeletal symptoms. Their
descriptionofacutecases(24)wassimilartootherobservations
(25). TheirexperimentalstudiesafterasingleMICexposureat
3.2 mg/L for 8 min. (26) showed thickening ofalveoar septa,
lymphoid hyperplasia, peripheral emphysema,peribronchial
edema, and cellular infiltrates with exfoliatedbronchiolar
epithelium. these findings are similar to those ofBucher etal.
(16-18).
Ourclinicalandfunctionaldataonfollowupamplifyindetail
someofthelungchanges. Ourdevelopmentofapredictive model
isunique inanoccupational setting, although thishasbeendone
by several researchersonexperimentalorclinicalproblems. This
effortmighthelpindelineatingthefuturecourseofhumaneffects
in relation to such an industrial disaster.
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